Israel's XTL, Medica To Buy U.S. Device Maker InterCure
This article was originally published in PharmAsia News
Executive Summary
Israel's XTL Biopharmaceuticals plans to acquire U.S.-based InterCure, a medical-device maker for lowering hypertension.